Furthermore, c-Jun N-terminal kinase (JNK) inhibitor SP600125 attenuated TNF-α expression decrease and survival rate enhancement of ALF after DMY treatment, which suggested that DMY alleviated CCl4-induced acute liver injury via a JNK-dependent manner (Xie et al., 2015). The gene discussed is MAPK8; the disease is injury.